This message was sent to ##Email##
|
|
|
|
| |
Healio
A study of graft loss in black and white kidney transplant recipients in the U.S. Military Health System suggested broader implementation of a universal healthcare model could lessen racial disparities in outcomes after transplant.
READ MORE
Liver Transplantation
Drs. Agopian, Verna and Goldberg have provided an important assessment of liver transplant volumes across the United Network for Organ Sharing regions from February to March of 2019 and 2020. The study revealed a significant center‐based difference in volume of transplant particularly among centers located in the same metropolitan areas including New York City.
READ MORE
|
Promoted by
|
|
|
|
 |
Charité - Universitätsmedizin Berlin via ScienceDaily
A large international study has demonstrated the safety of new cell therapy approaches for use in kidney transplant recipients. Transplant recipients were shown to require lower levels of immunosuppression in order to prevent organ rejection. This reduces the risk of side effects such as viral infections.
READ MORE
News-Medical
Scientists from Nanjing University and University of Macau have transformed the spleen into a functioning liver in living mice, which could bring new hope for patients suffering from organ shortage worldwide.
READ MORE
University of Birmingham
A major study investigating the effectiveness of liver perfusion as a technique to improve the function of donor livers that would have otherwise been rejected has shown that up to seven in every 10 could be used after just four to six hours of the assessment.
READ MORE
 |
|
Promoted by
Veloxis Pharmaceuticals
Watch kidney transplant patients talk about their diagnoses and the importance of communication with their doctors and transplant teams. For these patients, switching therapies made sense.
|
|
American Journal of Transplantation
Ex‐vivo normothermic machine perfusion of donor kidneys prior to transplantation provides a platform for direct delivery of cellular therapeutics to optimise organ quality prior to transplantation.
READ MORE
Advertisement
Veloxis Pharmaceuticals
There are many factors that may put a graft at risk, such as infections, nephrotoxicity, declining adherence, and inadequate immunosuppression. It can be difficult to achieve a balance between overimmunosuppression and underimmunosuppression in kidney transplant patients, putting patients at risk.
Learn More
|
Pulmonology Advisor
Patients receiving lung transplants who had pneumocystis pneumonia had higher mortality rates than patients without pneumocystis pneumonia, according to study results published in Respiratory Medicine.
READ MORE
The Journal of Heart and Lung Transplantation
Early in the first thoracic transplant programs, renal
impairment resulting from treatment with calcineurin inhibitors such as cyclosporine or tacrolimus was recognized,
determining many patients' short- and long-term outcomes.
Most of the decline in renal function was irreversible, and
decreasing cyclosporine exposure reduced this decline. This
has since been confirmed in a randomized controlled trial in
thoracic transplantation recipients.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
